Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of CAD 425.20 billion. The enterprise value is 441.60 billion.

Market Cap	425.20B
Enterprise Value	441.60B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.18B

Valuation Ratios

The trailing PE ratio is 19.52 and the forward PE ratio is 16.99.

PE Ratio	19.52
Forward PE	16.99
PS Ratio	6.74
PB Ratio	14.74
P/TBV Ratio	70.01
P/FCF Ratio	25.80
P/OCF Ratio	15.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.25, with an EV/FCF ratio of 26.80.

EV / Earnings	20.27
EV / Sales	6.85
EV / EBITDA	13.25
EV / EBIT	14.15
EV / FCF	26.80

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.

Current Ratio	0.74
Quick Ratio	0.54
Debt / Equity	0.86
Debt / EBITDA	0.76
Debt / FCF	1.50
Interest Coverage	41.95

Financial Efficiency

Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.

Return on Equity (ROE)	88.12%
Return on Assets (ROA)	23.29%
Return on Invested Capital (ROIC)	47.91%
Return on Capital Employed (ROCE)	58.02%
Revenue Per Employee	815,590
Profits Per Employee	281,463
Employee Count	77,349
Asset Turnover	0.77
Inventory Turnover	1.22

Taxes

In the past 12 months, Novo Nordisk has paid 5.77 billion in taxes.

Income Tax	5.77B
Effective Tax Rate	20.93%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	7.42
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.81
Average Volume (20 Days)	23,842

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of CAD 63.13 billion and earned 21.79 billion in profits. Earnings per share was 4.89.

Revenue	63.13B
Gross Profit	53.44B
Operating Income	30.58B
Pretax Income	27.55B
Net Income	21.79B
EBITDA	32.34B
EBIT	30.58B
Earnings Per Share (EPS)	4.89

Full Income Statement

Balance Sheet

The company has 8.65 billion in cash and 24.73 billion in debt, giving a net cash position of -16.07 billion.

Cash & Cash Equivalents	8.65B
Total Debt	24.73B
Net Cash	-16.07B
Net Cash Per Share	n/a
Equity (Book Value)	28.85B
Book Value Per Share	6.50
Working Capital	-12.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 27.33 billion and capital expenditures -10.85 billion, giving a free cash flow of 16.48 billion.

Operating Cash Flow	27.33B
Capital Expenditures	-10.85B
Free Cash Flow	16.48B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.

Gross Margin	84.65%
Operating Margin	48.43%
Pretax Margin	43.65%
Profit Margin	34.51%
EBITDA Margin	51.23%
EBIT Margin	48.43%
FCF Margin	26.10%

Dividends & Yields

Novo Nordisk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.61%
Buyback Yield	0.61%
Shareholder Yield	n/a
Earnings Yield	5.12%
FCF Yield	3.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 7.88 and a Piotroski F-Score of 5.

Altman Z-Score	7.88
Piotroski F-Score	5